No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr1:151813400-151821200 |
Weak transcription |
Primary Natural Killer cells fromperipheralblood |
blood
|
2 |
chr1:151813400-151828600 |
Weak transcription |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
3 |
chr1:151814800-151827400 |
Weak transcription |
Breast Myoepithelial Primary Cells |
Breast
|
4 |
chr1:151818400-151824400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
5 |
chr1:151818600-151821000 |
Enhancers |
HUES6 Cell Line |
embryonic stem cell
|
6 |
chr1:151819200-151825200 |
Weak transcription |
Gastric |
stomach
|
7 |
chr1:151819200-151827200 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
8 |
chr1:151819200-151847600 |
Weak transcription |
Thymus |
Thymus
|
9 |
chr1:151819400-151821800 |
Weak transcription |
Primary T helper memory cells from peripheral blood 1 |
blood
|
10 |
chr1:151819800-151821400 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
11 |
chr1:151820000-151825800 |
Weak transcription |
Hela-S3 |
cervix
|
12 |
chr1:151820200-151821000 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
13 |
chr1:151820200-151821800 |
Enhancers |
HUVEC |
blood vessel
|
14 |
chr1:151820400-151821400 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
15 |
chr1:151820400-151821400 |
Enhancers |
Ovary |
ovary
|
16 |
chr1:151820400-151821400 |
Enhancers |
Spleen |
Spleen
|
17 |
chr1:151820400-151821600 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
18 |
chr1:151820400-151821600 |
Enhancers |
Primary T regulatory cells fromperipheralblood |
blood
|
19 |
chr1:151820400-151821600 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
20 |
chr1:151820400-151821600 |
Enhancers |
Lung |
lung
|
21 |
chr1:151820400-151822000 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
22 |
chr1:151820400-151822400 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
23 |
chr1:151820400-151822400 |
Enhancers |
Fetal Lung |
lung
|
24 |
chr1:151820600-151821800 |
Enhancers |
Primary T cells fromperipheralblood |
blood
|
25 |
chr1:151820600-151822000 |
Bivalent Enhancer |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
26 |
chr1:151820600-151827200 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
27 |
chr1:151820800-151821000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
28 |
chr1:151820800-151821000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
29 |
chr1:151820800-151821000 |
Genic enhancers |
Right Atrium |
heart
|
30 |
chr1:151820800-151821200 |
Enhancers |
iPS-15b Cell Line |
embryonic stem cell
|
31 |
chr1:151820800-151821400 |
Enhancers |
HSMMtube |
muscle
|
32 |
chr1:151820800-151821600 |
Enhancers |
Primary T helper memory cells from peripheral blood 2 |
blood
|
33 |
chr1:151820800-151821600 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
34 |
chr1:151820800-151822000 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
35 |
chr1:151820800-151822000 |
Enhancers |
Adipose Nuclei |
Adipose
|
36 |
chr1:151820800-151822200 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
37 |
chr1:151820800-151822200 |
Enhancers |
Primary T helper 17 cells PMA-I stimulated |
--
|